ACADIA Pharmaceuticals Inc (ACAD)
14.79
-0.06
(-0.40%)
USD |
NASDAQ |
May 17, 16:00
14.78
-0.02
(-0.10%)
After-Hours: 20:00
ACADIA Pharmaceuticals Market Cap: 2.444B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.444B |
| May 16, 2024 | 2.454B |
| May 15, 2024 | 2.498B |
| May 14, 2024 | 2.455B |
| May 13, 2024 | 2.508B |
| May 10, 2024 | 2.520B |
| May 09, 2024 | 2.513B |
| May 08, 2024 | 2.830B |
| May 07, 2024 | 2.850B |
| May 06, 2024 | 2.809B |
| May 03, 2024 | 2.817B |
| May 02, 2024 | 2.822B |
| May 01, 2024 | 2.817B |
| April 30, 2024 | 2.761B |
| April 29, 2024 | 2.825B |
| April 26, 2024 | 2.761B |
| April 25, 2024 | 2.694B |
| April 24, 2024 | 2.741B |
| April 23, 2024 | 2.766B |
| April 22, 2024 | 2.807B |
| April 19, 2024 | 2.775B |
| April 18, 2024 | 2.816B |
| April 17, 2024 | 2.836B |
| April 16, 2024 | 2.818B |
| April 15, 2024 | 2.786B |
| Date | Value |
|---|---|
| April 12, 2024 | 2.827B |
| April 11, 2024 | 2.872B |
| April 10, 2024 | 2.925B |
| April 09, 2024 | 2.994B |
| April 08, 2024 | 2.936B |
| April 05, 2024 | 2.971B |
| April 04, 2024 | 2.978B |
| April 03, 2024 | 3.039B |
| April 02, 2024 | 2.987B |
| April 01, 2024 | 3.012B |
| March 28, 2024 | 3.047B |
| March 27, 2024 | 2.999B |
| March 26, 2024 | 2.931B |
| March 25, 2024 | 2.940B |
| March 22, 2024 | 2.958B |
| March 21, 2024 | 3.033B |
| March 20, 2024 | 3.075B |
| March 19, 2024 | 3.081B |
| March 18, 2024 | 3.085B |
| March 15, 2024 | 3.045B |
| March 14, 2024 | 3.086B |
| March 13, 2024 | 3.223B |
| March 12, 2024 | 3.292B |
| March 11, 2024 | 3.976B |
| March 08, 2024 | 3.862B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.100B
Minimum
Jun 21 2022
9.028B
Maximum
Dec 01 2020
4.554B
Average
3.889B
Median
Jul 01 2019
Market Cap Benchmarks
| Regulus Therapeutics Inc | 130.93M |
| Amylyx Pharmaceuticals Inc | 124.45M |
| Alnylam Pharmaceuticals Inc | 18.90B |
| Cassava Sciences Inc | 1.109B |
| Oragenics Inc | 10.44M |
Market Cap Related Metrics
| PS Ratio | 3.002 |
| Price to Book Value | 5.266 |
| Price to Free Cash Flow | 38.34 |
| Price | 14.79 |
| Earnings Yield | -0.07% |